These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 11812368)
1. [Pathologic review of 5,050 pulmonary tuberculosis cases]. Huang Z; Zhou M; Lü F Zhonghua Jie He He Hu Xi Za Zhi; 1999 Mar; 22(3):153-5. PubMed ID: 11812368 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
4. [Classification of destructive pulmonary tuberculosis into groups according to quantitative and qualitative characteristics with the aim of developing differentiated treatment methods]. Smirnov GA; Valiev RSh Probl Tuberk; 1999; (5):11-4. PubMed ID: 10565207 [TBL] [Abstract][Full Text] [Related]
5. [Efficiency of a new standard chemotherapy regimen in the treatment of patients with recurrent pulmonary tuberculosis]. Chukanov VI; Komissarova OG; Maishin VIu; Abdullaev RIu; Kononets AS Probl Tuberk Bolezn Legk; 2006; (8):9-13. PubMed ID: 17002050 [TBL] [Abstract][Full Text] [Related]
8. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains]. Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654 [TBL] [Abstract][Full Text] [Related]
9. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis]. Kawakami K Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849 [TBL] [Abstract][Full Text] [Related]
11. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM; Goldberg SV Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [TBL] [Abstract][Full Text] [Related]
12. [A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis]. Chen QL; Chen L; Yin JJ Zhonghua Jie He He Hu Xi Za Zhi; 2003 Aug; 26(8):454-7. PubMed ID: 14505519 [TBL] [Abstract][Full Text] [Related]
13. [Relapse rate of pulmonary tuberculosis within two years following completion of twice weekly intermittent chemotherapy]. Wada M; Okumura M; Hoshino H; Mitarai S; Ohmori M; Uchimura K; Yoshiyama T; Ogata H Kekkaku; 2008 Apr; 83(4):353-8. PubMed ID: 18516898 [TBL] [Abstract][Full Text] [Related]
14. Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus? Tortajada C; Martínez-Lacasa J; Sánchez F; Jiménez-Fuentes A; De Souza ML; García JF; Martínez JA; Caylà JA; Int J Tuberc Lung Dis; 2005 Mar; 9(3):276-81. PubMed ID: 15786890 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
16. [Twice-weekly intermittent chemotherapy during the maintenance phase of the short-course treatment for new patients with pulmonary tuberculosis]. Wada M; Mizoguchi K; Okumura M; Mitarai S; Hoshino H; Ohmori M; Uchimura K; Yoshiyama T; Ogata H Kekkaku; 2006 May; 81(5):363-9. PubMed ID: 16768170 [TBL] [Abstract][Full Text] [Related]
17. [Efficiency of retrosternal lymphotropic chemotherapy in the treatment of new cases of destructive pulmonary tuberculosis]. Kibrik BS; Zakharov AV Probl Tuberk Bolezn Legk; 2009; (4):23-7. PubMed ID: 19514450 [TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy for tuberculosis in children and adolescents: problems and ways of their solution]. Ovsiankina ES; Gubkina MF; Kobulashvili MG; Panova LV Probl Tuberk Bolezn Legk; 2006; (8):26-9. PubMed ID: 17002054 [TBL] [Abstract][Full Text] [Related]